Journal of Research in Dental
and Maxillofacial Sciences
Volume 11, Issue 2 (6-2026)
J Res Dent Maxillofac Sci 2026, 11(2): 136-147 |
Back to browse issues page
Ethics code: 0972/HRECC.FODM/IX/2024
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rachmadhan F F, Kamadjaja D B, Al Fessi R. In Vitro Study of Sustained Release Potential and IGF/PDGF Profile of Lyophilized Decellularized Bovine Bone Scaffolds After Freeze-Dried Secretome Application. J Res Dent Maxillofac Sci 2026; 11 (2) :136-147
URL: http://jrdms.dentaliau.ac.ir/article-1-1266-en.html
URL: http://jrdms.dentaliau.ac.ir/article-1-1266-en.html
1- CClinical Medicine Magister Study Programme, Faculty of Dental Medicine, Universitas Airlangga, Surabaya 60132, Indonesia
2- Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Universitas Airlangga, Surabaya 60132, Indonesia ,david-b-k@fkg.unair.ac.id
3- Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Universitas Airlangga, Surabaya 60132, Indonesia
2- Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Universitas Airlangga, Surabaya 60132, Indonesia ,
3- Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Universitas Airlangga, Surabaya 60132, Indonesia
Abstract: (5 Views)
Background and Aim: Craniomaxillofacial bone defects are commonly reconstructed using bovine bone scaffolds, where stable growth factor release is critical for effective bone regeneration. This study investigated the release profile of insulin-like growth factor (IGF) and platelet-derived growth factor (PDGF) from deproteinized bovine bone mineral (DBBM), freeze-dried bovine bone (FDBB), and decellularized freeze-dried bovine bone (dc-FDBB) scaffolds following application of freeze-dried secretome.
Materials and Methods: In this in vitro experimental study, scaffolds were first immersed in secretome and incubated at 4°C for 24 hours to facilitate absorption, followed by an optional freeze-drying step. After rehydration, the release kinetics of IGF and PDGF was measured at 1, 8, 24, and 48 hours using ELISA. Comparisons were made with one-way ANOVA followed by the Tukey’s HSD test (alpha=0.05).
Results: FDBB scaffolds treated with freeze-dried secretome exhibited the highest and most sustained release of IGF over 48 hours compared to other groups (26.774±4.079 ng/mL; P<0.05); while PDGF release was generally lower in freeze-dried groups compared to controls (8.587±2.184 ng/mL; P=0.197).
Conclusion: The results showed that freeze-drying influences the release profile of IGF and PDGF and its sustainability from secretome-loaded bovine bone scaffolds, with potential implications for optimizing scaffold bioactivity in bone tissue engineering applications.
Materials and Methods: In this in vitro experimental study, scaffolds were first immersed in secretome and incubated at 4°C for 24 hours to facilitate absorption, followed by an optional freeze-drying step. After rehydration, the release kinetics of IGF and PDGF was measured at 1, 8, 24, and 48 hours using ELISA. Comparisons were made with one-way ANOVA followed by the Tukey’s HSD test (alpha=0.05).
Results: FDBB scaffolds treated with freeze-dried secretome exhibited the highest and most sustained release of IGF over 48 hours compared to other groups (26.774±4.079 ng/mL; P<0.05); while PDGF release was generally lower in freeze-dried groups compared to controls (8.587±2.184 ng/mL; P=0.197).
Conclusion: The results showed that freeze-drying influences the release profile of IGF and PDGF and its sustainability from secretome-loaded bovine bone scaffolds, with potential implications for optimizing scaffold bioactivity in bone tissue engineering applications.
Type of Study: Original article |
Subject:
Oral & maxillofacial surgery
References
1. Chuxi Z, Xinkang Z, Xiaokun D, Shilei Z, Xinrong C. CMF defects database: A craniomaxillofacial defects dataset and a data-driven repair method. Biomed Signal Process Control. 2024 May;91:105939. [DOI:10.1016/j.bspc.2023.105939]
2. Verbist M, Vandevelde AL, Geusens J, Sun Y, Shaheen E, Willaert R. Reconstruction of craniomaxillofacial bone defects with 3D-printed bioceramic implants: Scoping review and clinical case series. J Clin Med. 2024 May;13(10): 2805. [DOI:10.3390/jcm13102805] [PMID] [PMCID]
3. de Carvalho AB, Rahimnejad M, Oliveira RL, Sikder P, Saavedra GS, Bhaduri SB, et al. Personalized bioceramic grafts for craniomaxillofacial bone regeneration. Int J Oral Sci. 2024 Oct;16(1):62. [DOI:10.1038/s41368-024-00327-7] [PMID] [PMCID]
4. Dewey MJ, Harley BAC. Biomaterial design strategies to address obstacles in craniomaxillofacial bone repair. RSC Adv. 2021;11(29):17809-27. [DOI:10.1039/D1RA02557K] [PMID]
5. Zhou Y, You D, Xu M, Shao Y, Hu X, Xie Y, et al. Bionic repair strategy for craniomaxillofacial bone tissue reconstruction. Transl Dent Res. 2025 Jul;1(3):100037. [DOI:10.1016/j.tdr.2025.100037]
6. Schmidt AH. Autologous bone graft: Is it still the gold standard? Injury. 2021 Jun;52:S18-22. [DOI:10.1016/j.injury.2021.01.043] [PMID]
7. Robinson PG, Abrams GD, Sherman SL, Safran MR, Murray IR. Autologous Bone Grafting. Oper Tech Sports Med. 2020 Dec;28(4):150780. [DOI:10.1016/j.otsm.2020.150780]
8. Gillman CE, Jayasuriya AC. FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater Sci Eng C. 2021 Nov;130:112466. [DOI:10.1016/j.msec.2021.112466] [PMID] [PMCID]
9. Budiatin AS, Khotib J, Samirah S, Ardianto C, Gani MA, Putri BR, et al. Acceleration of bone fracture healing through the use of bovine hydroxyapatite or calcium lactate oral and implant bovine hydroxyapatite - Gelatin on bone defect animal model. Polymers (Basel). 2022 Nov; 14(22):4812. [DOI:10.3390/polym14224812] [PMID] [PMCID]
10. Widhiyanto L, Utomo DN, Perbowo AP, Hernugrahanto KD. Macroscopic and histologic evaluation of cartilage regeneration treated using xenogenic biodegradable porous sponge cartilage scaffold composite supplemented with allogenic adipose derived mesenchymal stem cells (ASCs) and secretome: An in vivo experiment. J Biomater Appl. 2020 Sep;35(3):422-9. [DOI:10.1177/0885328220934938] [PMID]
11. Suyatno A, Nurfinti WO, Kusuma CPA, Pratama YA, Ardianto C, Samirah S, et al. Effectiveness of Bilayer Scaffold Containing Chitosan / Gelatin / Diclofenac and Bovine Hydroxyapatite on Cartilage / Subchondral Regeneration in Rabbit Joint Defect Models. Adv Pharmacol Pharm Sci. 2024;2024(1):6987676. [DOI:10.1155/2024/6987676] [PMID] [PMCID]
12. Pratama YA, Ananta IP, Haris MS, Maghfiroh N, Nabila H, Ardianto C, et al. Accelerated bone defect closure after administration of nano bovine hydroxyapatite-calcium sulfate-gelatin scaffold in bone defect models. J Pharm Pharmacogn Res. 2025 Nov;13(6):1728-41. [DOI:10.56499/jppres24.2310_13.6.1728]
13. Pratama YA, Marhaeny HD, Deapsari F, Budiatin AS, Rahmadi M, Miatmoko A, et al. Development of Hydroxyapatite as a Bone Implant Biomaterial for Triggering Osteogenesis. Eur J Dent. 2025 May. Epub ahead of print. [DOI:10.1055/s-0045-1809312] [PMID] [PMCID]
14. Zhu YW, Wei YW, Ma JY, Chen W, Shen Z, Qiu J. Bioactive deproteinized bovine bone mineral based on self-assembled albumin nanoparticles promoted bone regeneration via activation of Wnt/β-catenin pathway. Mater Today Bio. 2025 Jun;32:101730. [DOI:10.1016/j.mtbio.2025.101730] [PMID] [PMCID]
15. Parisi L, Buser D, Chappuis V, Asparuhova MB. Cellular responses to deproteinized bovine bone mineral biofunctionalized with bone-conditioned medium. Clin Oral Investig. 2021 Apr;25(4):2159-73. [DOI:10.1007/s00784-020-03528-6] [PMID] [PMCID]
16. Nugraha AP, Kamadjaja DB, Sumarta NPM, Rizqiawan A, Pramono C, Yuliati A, et al. Osteoinductive and osteogenic capacity of freeze-dried bovine bone compared to deproteinized bovine bone mineral scaffold in human umbilical cord mesenchymal stem cell culture: An in vitro study. Eur J Dent. 2023 Oct;17(4):1106-13. [DOI:10.1055/s-0042-1758786] [PMID] [PMCID]
17. Vidarta RP, Kamadjaja DB, Danudiningrat CP, Amir MS, Rizqiawan A, Yuliati A, et al. Degradation rate and weight loss analysis for freeze-dried, decellularized, and deproteinized bovine bone scaffolds. Dent J. 2025 Mar;58(1):23-9. [DOI:10.20473/j.djmkg.v58.i1.p23-29]
18. Sahetapy OM, Kamadjaja DB, Danudiningrat CP, Rizqiawan A. Comparative study of biomechanical characteristics of deproteinized and decellularized bovine bone block scaffold. J Int Dent Med Res. 2025 May;18(2):594-8.
19. Bracey DN, Jinnah AH, Willey JS, Seyler TM, Hutchinson ID, Whitlock PW, et al. Investigating the osteoinductive potential of a decellularized xenograft bone substitute. Cells Tissues Organs. 2019 Nov;207(2):97-113. [DOI:10.1159/000503280] [PMID] [PMCID]
20. El Moshy S, Radwan IA, Rady D, Abbass MM, El-Rashidy AA, Sadek KM, et al. Dental stem cell-derived secretome/conditioned medium: The future for regenerative therapeutic applications. Stem Cells Int. 2020;2020(1):7593402. [DOI:10.1155/2020/7593402] [PMID] [PMCID]
21. Iaquinta MR, De Pace R, Benkhalqui A, D'Agostino A, Trevisiol L, Finotti A, et al. Secretome release during in vitro bone marrow-derived mesenchymal stem cell differentiation induced by Bio-Oss® collagen material. Int J Mol Sci. 2025 Apr;26(8): 3807. [DOI:10.3390/ijms26083807] [PMID] [PMCID]
22. Perwira FD, Utomo DN, Widhiyanto L, Hernugrahanto KD. Physiobiochemical and microbiologic stability characteristics of freeze-dried cartilage secretome Adipose Mesenchymal Stem Cell (AdMSC). Int J Health Sci (Qassim). 2022;6(S5):7584-93. [DOI:10.53730/ijhs.v6nS5.11641]
23. Trigo CM, Rodrigues JS, Camões SP, Solá S, Miranda JP. Mesenchymal stem cell secretome for regenerative medicine : Where do we stand ? J Adv Res. 2025 Apr;70:103-24. [DOI:10.1016/j.jare.2024.05.004] [PMID] [PMCID]
24. Putra ZK, Mahyudin F, Suroto H. Comparison of five growth factors in the secretomes of hypoxic bone marrow mesenchymal stem cells and hypoxic adipose mesenchymal stem cells. Bali Med J. 2024 Jan;13(1):577-81. [DOI:10.15562/bmj.v13i1.5155]
25. Cecerska-Heryć E, Goszka M, Serwin N, Roszak M, Grygorcewicz B, Heryć R, et al. Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev. 2022 Apr;64:84-94. [DOI:10.1016/j.cytogfr.2021.11.003] [PMID]
26. Prado-Yupanqui JW, Ramírez-Orrego L, Cortez D, Vera-Ponce VJ, Chenet SM, Tejedo JR, et al. The hidden power of the secretome: Therapeutic potential on wound healing and cell-free regenerative medicine-A systematic review. Int J Mol Sci. 2025 Feb;26(5):1926. [DOI:10.3390/ijms26051926] [PMID] [PMCID]
27. Nur A, Putri K, Rizqiawan A, Amir MS. Preosteoblast adhesion and viability study of freeze-dried bovine bone block scaffold coated with human umbilical cord mesenchymal stem cell secretome. Eur J Dent. 2025 Feb;19(01):197-205. [DOI:10.1055/s-0044-1787105] [PMID] [PMCID]
28. Charan J, Kantharia N. How to calculate sample size in animal studies? J Pharmacol Pharmacother. 2013 Dec;4(4):303-6. [DOI:10.4103/0976-500X.119726] [PMID] [PMCID]
29. Cheng L, Liu J, Wang Q, Hu H, Zhou L. The protective effect of a human umbilical cord mesenchymal stem cell supernatant on UVB-induced skin photodamage. Cells. 2024;13(2):156. doi:10.3390/cells13020156. [DOI:10.3390/cells13020156] [PMID] [PMCID]
30. Merivaara A, Zini J, Koivunotko E, Valkonen S, Korhonen O, Fernandes FM, et al. Preservation of biomaterials and cells by freeze-drying: Change of paradigm. J Control Release. 2021 Aug;336:480-98. [DOI:10.1016/j.jconrel.2021.06.042] [PMID] [PMCID]
31. Fu JN, Wang X, Yang M, Chen YR, Zhang JY, Deng RH, et al. Scaffold-based tissue engineering strategies for osteochondral repair. Front Bioeng Biotechnol. 2022 Jan;9:812383. [DOI:10.3389/fbioe.2021.812383] [PMID] [PMCID]
32. Feng J, Meng Z. Insulin growth factor‑1 promotes the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells through the Wnt/β‑catenin pathway. Exp Ther Med. 2021 Aug;22(2):891. [DOI:10.3892/etm.2021.10323] [PMID] [PMCID]
33. Wang S, Umrath F, Cen W, Reinert S, Alexander D. Angiogenic potential of vegf mimetic peptides for the biofunctionalization of collagen/hydroxyapatite composites. Biomolecules. 2021 Oct;11(10):1538. [DOI:10.3390/biom11101538] [PMID] [PMCID]
34. Wang Z, Zhu P, Li H, Ye B, Luo Q, Cheng J, et al. Sodium hyaluronate-PDGF repairs cartilageand subchondral bone microenvironment via HIF-1α-VEGF-notch and SDF-1-CXCR4 inhibitionin osteoarthritis. J Cell Mol Med Orig. 2025 Apr;29(7):e70515. [DOI:10.1111/jcmm.70515] [PMID] [PMCID]
35. Xu J, Wang Y, Li Z, Tian Y, Li Z, Lu A, et al. PDGFRα reporter activity identifies periosteal progenitor cells critical for bone formation and fracture repair. Bone Res. 2022 Jan;10(1):7. [DOI:10.1038/s41413-021-00176-8] [PMID] [PMCID]
36. Ashraf S, Burston JJ, Shahtaheri M, McWilliams DF, Chapman V, de Moor CH, et al. Osteocyte phenotypes in human and monoiodoacetate-induced rat osteoarthritis. Osteoarthr Cartil. 2022 Apr;30:S319. [DOI:10.1016/j.joca.2022.02.422]
37. Lerner UH, Kindstedt E, Lundberg P. The critical interplay between bone resorbing and bone forming cells. J Clin Periodontol. 2019 Jun;46:33-51. [DOI:10.1111/jcpe.13051] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |